順威股份(002676.SZ):順威新能源擬參設穗開智境基金 以投資超境控股
格隆匯2月24日丨順威股份(002676.SZ)公佈,公司全資子公司廣州順威新能源汽車有限公司(簡稱“順威新能源”)擬與廣州穗開股權投資有限公司(簡稱“穗開投資”、“關聯方”)、廣州匯田智慧運營有限公司(簡稱“匯田智慧”)、劉紅、曾鋒、戴德和共同合作設立廣州穗開智境股權投資合夥企業(有限合夥)(暫定名,最終以登記機關核准的名稱為準,簡稱“穗開智境基金”),專項用於投資廣州超境控股有限公司(簡稱“超境控股”)。該基金規模擬定為4350萬元,其中順威新能源作為有限合夥人以自有資金出資人民幣950萬元,佔合夥企業出資額的21.84%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.